Celastrol also lowered antiapoptotic (Bcl-xL, Mcl-1, and survivin) protein levels and induced apoptosis in CML cells harboring T135I mutation [108]. The gene discussed is BCL2L1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.